Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranolazine in women with microvascular coronary disease
NCT00570089Phase 2Completed
- Sponsor
- Cedars-Sinai Medical Center
- Start
- Apr 2007
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ranolazine in coronary microvascular disease (CMD), sponsored by Cedars-Sinai Medical Center. Started Apr 2007; status: completed.
02
Drugs
ranolazine
03
Conditions
coronary microvascular disease (CMD)
Beyond the preview
Go deeper on NCT00570089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00570089.